Your browser doesn't support javascript.
loading
Optimization of N-Piperidinyl-Benzimidazolone Derivatives as Potent and Selective Inhibitors of 8-Oxo-Guanine DNA Glycosylase 1.
Wallner, Olov; Cázares-Körner, Armando; Scaletti, Emma Rose; Masuyer, Geoffrey; Bekkhus, Tove; Visnes, Torkild; Mamonov, Kirill; Ortis, Florian; Lundbäck, Thomas; Volkova, Maria; Koolmeister, Tobias; Wiita, Elisée; Loseva, Olga; Pandey, Monica; Homan, Evert; Benítez-Buelga, Carlos; Davies, Jonathan; Scobie, Martin; Warpman Berglund, Ulrika; Kalderén, Christina; Stenmark, Pål; Helleday, Thomas; Michel, Maurice.
Afiliación
  • Wallner O; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 77, Stockholm, Sweden.
  • Cázares-Körner A; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 77, Stockholm, Sweden.
  • Scaletti ER; Department of Biochemistry and Biophysics, Stockholm University, 10691, Stockholm, Sweden.
  • Masuyer G; Department of Biochemistry and Biophysics, Stockholm University, 10691, Stockholm, Sweden.
  • Bekkhus T; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 77, Stockholm, Sweden.
  • Visnes T; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 77, Stockholm, Sweden.
  • Mamonov K; Department of Biotechnology and Nanomedicine, SINTEF Industry, 7465, Trondheim, Norway.
  • Ortis F; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 77, Stockholm, Sweden.
  • Lundbäck T; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 77, Stockholm, Sweden.
  • Volkova M; Chemical Biology Consortium Sweden (CBCS), Science for Life Laboratory, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 77, Stockholm, Sweden.
  • Koolmeister T; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 77, Stockholm, Sweden.
  • Wiita E; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 77, Stockholm, Sweden.
  • Loseva O; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 77, Stockholm, Sweden.
  • Pandey M; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 77, Stockholm, Sweden.
  • Homan E; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 77, Stockholm, Sweden.
  • Benítez-Buelga C; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 77, Stockholm, Sweden.
  • Davies J; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 77, Stockholm, Sweden.
  • Scobie M; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.
  • Warpman Berglund U; Department of Biochemistry and Biophysics, Stockholm University, 10691, Stockholm, Sweden.
  • Kalderén C; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 77, Stockholm, Sweden.
  • Stenmark P; Oxcia AB, 113 34, Stockholm, Sweden.
  • Helleday T; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 77, Stockholm, Sweden.
  • Michel M; Oxcia AB, 113 34, Stockholm, Sweden.
ChemMedChem ; 18(1): e202200310, 2023 01 03.
Article en En | MEDLINE | ID: mdl-36128847

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: ADN Glicosilasas / Neoplasias Límite: Humans Idioma: En Revista: ChemMedChem Asunto de la revista: FARMACOLOGIA / QUIMICA Año: 2023 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: ADN Glicosilasas / Neoplasias Límite: Humans Idioma: En Revista: ChemMedChem Asunto de la revista: FARMACOLOGIA / QUIMICA Año: 2023 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Alemania